Ramagopalan Sreeram V, Morris Andrew P, Dyment David A, Herrera Blanca M, DeLuca Gabriele C, Lincoln Matthew R, Orton Sarah M, Chao Michael J, Sadovnick A Dessa, Ebers George C
Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom.
PLoS Genet. 2007 Sep;3(9):1607-13. doi: 10.1371/journal.pgen.0030150. Epub 2007 Jul 20.
Multiple sclerosis (MS) is a complex trait in which alleles at or near the class II loci HLA-DRB1 and HLA-DQB1 contribute significantly to genetic risk. HLA-DRB115 and HLA-DRB117-bearing haplotypes and interactions at the HLA-DRB1 locus increase risk of MS but it has taken large samples to identify resistance HLA-DRB1 alleles. In this investigation of 7,093 individuals from 1,432 MS families, we have assessed the validity, mode of inheritance, associated genotypes, and the interactions of HLA-DRB1 resistance alleles. HLA-DRB114-, HLA-DRB111-, HLA-DRB101-, and HLA-DRB110-bearing haplotypes are protective overall but they appear to operate by different mechanisms. The first type of resistance allele is characterised by HLA-DRB114 and HLA-DRB111. Each shows a multiplicative mode of inheritance indicating a broadly acting suppression of risk, but a different degree of protection. In contrast, a second type is exemplified by HLA-DRB110 and HLA-DRB101. These alleles are significantly protective when they interact specifically in trans with HLA-DRB115-bearing haplotypes. HLA-DRB101 and HLA-DRB110 do not interact with HLA-DRB117, implying that several mechanisms may be operative in major histocompatibility complex-associated MS susceptibility, perhaps analogous to the resistance alleles. There are major practical implications for risk and for the exploration of mechanisms in animal models. Restriction of antigen presentation by HLA-DRB1*15 seems an improbably simple mechanism of major histocompatibility complex-associated susceptibility.
多发性硬化症(MS)是一种复杂性状,其中II类基因座HLA - DRB1和HLA - DQB1处或其附近的等位基因对遗传风险有显著贡献。携带HLA - DRB115和HLA - DRB117的单倍型以及HLA - DRB1基因座处的相互作用会增加MS风险,但需要大样本才能识别出抗性HLA - DRB1等位基因。在这项对来自1432个MS家族的7093名个体的研究中,我们评估了HLA - DRB1抗性等位基因的有效性、遗传模式、相关基因型及其相互作用。携带HLA - DRB114、HLA - DRB111、HLA - DRB101和HLA - DRB110的单倍型总体上具有保护作用,但它们似乎通过不同机制起作用。第一种抗性等位基因以HLA - DRB114和HLA - DRB111为特征。每种都显示出相乘遗传模式,表明对风险有广泛作用的抑制,但保护程度不同。相比之下,第二种类型以HLA - DRB110和HLA - DRB101为例。当它们与携带HLA - DRB115的单倍型在反式中特异性相互作用时,这些等位基因具有显著的保护作用。HLA - DRB101和HLA - DRB110不与HLA - DRB117相互作用,这意味着几种机制可能在主要组织相容性复合体相关的MS易感性中起作用,可能类似于抗性等位基因。这对风险以及动物模型中机制的探索具有重要的实际意义。由HLA - DRB1*15限制抗原呈递似乎不太可能是主要组织相容性复合体相关易感性的简单机制。